naltrexone has been researched along with Nerve Pain in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 13 (65.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, SM; Dieckmann, G; Engert, RC; Hamrah, P; Ozmen, MC | 1 |
| Bilbrey, JA; Felix, JS; McCurdy, CR; McMahon, LR; Wilkerson, JL | 1 |
| Augusto, PSA; Brito, AMS; Coelho, MM; Costa, SOAM; Dutra, MGMB; Godin, AM; Goulart, FA; Ísis Morais, M; Machado, RR; Melo, ISF; Menezes, RR; Rodrigues, FF | 1 |
| Hein, M; Ji, G; Navratilova, E; Neugebauer, V; Phelps, C; Porreca, F; Qu, C; Yakhnitsa, V | 1 |
| Bannister, K; Dickenson, AH; Navratilova, E; Phelps, CE; Porreca, F | 1 |
| Augusto, PSA; Batista, CRA; Braga, AV; Coelho, MM; Costa, SOAM; Dutra, MMGB; Goulart, FA; Machado, RR; Melo, ISF; Morais, MI; Rodrigues, FF | 1 |
| Gibbons, CR; Levitch, BR; Liu, S; Moehlmann, SB; Quock, RM; Sayre, CL; Shirachi, DY; Zhang, Y | 1 |
| Ellis, A; Falci, S; Favret, J; Johnson, KW; Maier, SF; Rice, KC; Watkins, LR; Wieseler, J | 1 |
| Gao, MJ; Kao, JH; Law, PY; Loh, HH; Tao, PL; Yang, PP | 1 |
| Barrot, M; Bohren, Y; Doridot, S; Freund-Mercier, MJ; Gaveriaux-Ruff, C; Kieffer, BL; Megat, S; Yalcin, I | 1 |
| Schairer, J; Thapa, SD | 1 |
| Ayala, M; Ellis, A; Falci, S; Favret, J; Grace, PM; Hutchinson, MR; Maier, SF; Rice, KC; Skarda, B; Springer, K; Watkins, LR; Wieseler, J | 1 |
| Barrot, M; Bohren, Y; Freund-Mercier, MJ; Gavériaux-Ruff, C; Karavelic, D; Kieffer, BL; Tessier, LH; Yalcin, I | 1 |
| Henriksen, EJ; Ibrahim, MM; Mata, HP; Philip Malan, T; Porreca, F; Stagg, NJ; Vanderah, TW | 1 |
| Johanek, LM; King, EW; Sato, KL; Sluka, KA | 1 |
| Hareyama, N; Kaneko, C; Kuzumaki, N; Miyatake, M; Miyoshi, K; Nagumo, Y; Nakajima, M; Narita, M; Sato, F; Seyama, Y; Shindo, K; Suzuki, T; Wachi, H | 1 |
| Burns, LH; Guo, W; Largent-Milnes, TM; Vanderah, TW; Wang, HY | 1 |
| Huang, FS; Tang, JS; Wang, JY; Yuan, YK; Zhao, M | 1 |
| Mika, J; Przewłocka, B; Przewłocki, R | 1 |
| Burgess, SE; Gardell, LR; Lai, J; Lappi, DA; Malan, TP; Ossipov, MH; Porreca, F; Vanderah, TW | 1 |
20 other study(ies) available for naltrexone and Nerve Pain
| Article | Year |
|---|---|
Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.
Topics: Cornea; Female; Humans; Naltrexone; Neuralgia; Quality of Life; Retrospective Studies | 2021 |
Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine.
Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Neuralgia; Stavudine | 2021 |
Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF-α and CXCL-1.
Topics: Animals; Chemokine CXCL1; Glyburide; Hyperalgesia; Isoxazoles; Leflunomide; Male; Mice; Naltrexone; Neuralgia; Tumor Necrosis Factor-alpha | 2018 |
Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain.
Topics: Animals; Central Amygdaloid Nucleus; Chronic Pain; Disease Models, Animal; Hyperalgesia; In Vitro Techniques; Male; Membrane Potentials; Naltrexone; Narcotic Antagonists; Neural Inhibition; Neuralgia; Neurons; Pain Threshold; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Signal Transduction; Synaptic Transmission | 2019 |
Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain.
Topics: Amygdala; Animals; Chronic Pain; Diffuse Noxious Inhibitory Control; Electrophysiological Phenomena; Functional Laterality; Hindlimb; Hyperalgesia; Ligation; Male; Naltrexone; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Signal Transduction; Spinal Nerves | 2019 |
Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms.
Topics: Analgesics; Animals; Disease Models, Animal; Female; Glyburide; Hyperalgesia; Metformin; Mice; Naltrexone; Neuralgia; Nociception; Psychomotor Performance; Receptors, Opioid | 2019 |
Involvement of brain opioid receptors in the anti-allodynic effect of hyperbaric oxygen in rats with sciatic nerve crush-induced neuropathic pain.
Topics: Animals; Hyperalgesia; Hyperbaric Oxygenation; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Sciatic Nerve; Spinal Cord | 2013 |
Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.
Topics: Animals; Disease Models, Animal; Hyperalgesia; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Neuroglia; Neuroprotective Agents; Phosphodiesterase Inhibitors; Pyridines; Radiculopathy; Rats; Rats, Sprague-Dawley; Xanthines | 2014 |
Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.
Topics: Analgesics; Animals; Conditioning, Psychological; Genetic Vectors; HEK293 Cells; Humans; Lentivirus; Male; Mice, Inbred C57BL; Morphine; Mutation; Naltrexone; Narcotic Antagonists; Neuralgia; Receptors, Opioid, mu; Reward; Spinal Cord; Spinal Nerves; Substance Withdrawal Syndrome; Transfection | 2015 |
κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain.
Topics: Animals; Antidepressive Agents, Tricyclic; Male; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Neuralgia; Nortriptyline; Receptors, Opioid, delta; Receptors, Opioid, kappa; Sciatic Nerve | 2015 |
Narcotic-induced pain.
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Anorexia; Chronic Disease; Diabetes Mellitus, Type 1; Drug Administration Schedule; Endoscopy, Gastrointestinal; Gastroparesis; Humans; Hypertension; Kidney Failure, Chronic; Male; Naltrexone; Narcotic Antagonists; Nausea; Neuralgia; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome; Treatment Outcome; Vomiting | 2015 |
Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury.
Topics: Analgesics, Opioid; Animals; Hyperalgesia; Male; Morphine; Naltrexone; Neuralgia; Rats, Sprague-Dawley; Spinal Cord Injuries; Toll-Like Receptor 4 | 2016 |
Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Male; Mice; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Neuralgia; Nortriptyline; Pain Measurement; Receptors, Opioid, mu | 2010 |
Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids.
Topics: Animals; beta-Endorphin; Brain Stem; Disease Models, Animal; Enkephalin, Methionine; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Pain Threshold; Physical Conditioning, Animal; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2011 |
Spinal cord stimulation reduces hypersensitivity through activation of opioid receptors in a frequency-dependent manner.
Topics: Analgesics, Opioid; Animals; Hyperalgesia; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Neuralgia; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Spinal Cord; Spinal Cord Stimulation | 2013 |
Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction.
Topics: Animals; Anxiety Disorders; Astrocytes; Brain Tissue Transplantation; Cells, Cultured; Cerebral Cortex; Chronic Disease; Culture Media, Conditioned; Disease Models, Animal; Gliosis; Gyrus Cinguli; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Neuralgia; Pain, Intractable; Peripheral Nervous System Diseases; Receptors, Opioid, delta; Sciatic Neuropathy; Stem Cells | 2006 |
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hyperalgesia; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Oxycodone; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Signal Transduction; Spinal Nerves | 2008 |
Mu-opioid receptor in the nucleus submedius: involvement in opioid-induced inhibition of mirror-image allodynia in a rat model of neuropathic pain.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Enkephalin, Leucine-2-Alanine; Hyperalgesia; Ligation; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Neuralgia; Oligopeptides; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Spinal Nerves; Thalamic Nuclei | 2008 |
The role of delta-opioid receptor subtypes in neuropathic pain.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Benzylidene Compounds; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Isothiocyanates; Male; Naltrexone; Narcotic Antagonists; Neuralgia; Oligopeptides; Pain Measurement; Protein Isoforms; Rats; Rats, Wistar; Receptors, Opioid, delta; Sciatic Nerve; Time Factors | 2001 |
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.
Topics: Animals; Behavior, Animal; Brain Stem; Disease Models, Animal; Immunotoxins; Ligation; Male; Medulla Oblongata; Microinjections; N-Glycosyl Hydrolases; Naltrexone; Neuralgia; Neurons; Oligopeptides; Opioid Peptides; Pain Measurement; Physical Stimulation; Plant Proteins; Radioligand Assay; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Opioid, mu; Recombinant Fusion Proteins; Ribosome Inactivating Proteins, Type 1; Saporins; Spinal Nerves | 2001 |